Abstract
The neutrophil-to-lymphocyte ratio (NLR), a biomarker for systematic inflammation, has been recently identified as a prognostic factor for various types of both solid and hematologic malignancies. Here we conducted an updated dose-response meta-analysis to investigate whether NLR can be served as a prognostic biomarker in diffuse large B cell lymphoma (DLBCL). We systematically searched PubMed, Embase, ISI Web of Science and CNKI for relevant studies. Odds ratios or hazards ratios (HRs) with corresponding 95% confidence intervals (CIs) were pooled to estimate the association between NLR and clinicopathological parameters or survival of cancer patients. Eleven trials with 2515 DLBCL patients were included in the meta-analysis. The results revealed that elevated pretreatment NLR was significantly associated with elder age, advanced Ann Arbor stage, higher incidence rate of B symptoms and bone marrow involvement, and higher lactate dehydrogenase level, etc. Moreover, increased NLR also predicted poorer overall survival (HR 1.826, 95% CI 1.238-2.692) and progression-free survival/event-free survival (PFS/EFS) (HR 1.591, 95% CI 1.124-2.252). And two-stage dose-response meta-analysis revealed non-linear association between increased ...Continue Reading
References
Jan 28, 1999·Statistics in Medicine·M K ParmarL Stewart
Jun 21, 2002·The New England Journal of Medicine·Andreas RosenwaldUNKNOWN Lymphoma/Leukemia Molecular Profiling Project
Sep 25, 2003·Blood·Christine P HansWing C Chan
Jun 25, 2009·Cancer Research·Isabelle Ray-CoquardUNKNOWN European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group
Dec 17, 2009·Leukemia & Lymphoma·N George Mikhaeel
May 21, 2010·Leukemia·L F PorrataS N Markovic
Sep 16, 2010·American Journal of Hematology·Luis F PorrataSvetomir N Markovic
Feb 9, 2011·Blood·Elias CampoElaine S Jaffe
Aug 17, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jonathan W Friedberg
Dec 14, 2011·Hematology·Jonathan W Friedberg
Jun 8, 2012·PLoS Medicine·Douglas G AltmanSheila E Taube
Dec 12, 2012·Journal of Clinical Immunology·Juliana Candido, Thorsten Hagemann
Dec 21, 2013·British Journal of Cancer·K TroppanM Pichler
Mar 5, 2014·Annals of Hematology·Samir DaliaBijal Shah
Mar 15, 2014·Annals of Oncology : Official Journal of the European Society for Medical Oncology·R Vaidya, T E Witzig
Mar 19, 2014·European Urology·Boyd R ViersMatthew K Tollefson
May 14, 2014·Advances in Experimental Medicine and Biology·Antonino CarboneAnnunziata Gloghini
May 31, 2014·British Journal of Cancer·K T TroppanM Pichler
May 31, 2014·Journal of the National Cancer Institute·Arnoud J TempletonEitan Amir
Jun 28, 2014·Acta Haematologica·Sung-Hoon JungJe-Jung Lee
Nov 11, 2014·Leukemia & Lymphoma·Bhumsuk KeamDae Seog Heo
Jan 21, 2015·Frontiers in Psychology·Mike W-L Cheung
Jun 20, 2015·Medicine·Ching-Liang HoYi-Ying Wu
Jul 25, 2015·Scientific Reports·Xiao-Bin GuXiao-Jun Zhang
Dec 15, 2015·Journal of the National Comprehensive Cancer Network : JNCCN·Thomas MelchardtAlexander Egle
Sep 24, 2016·Medicine·Jing WangJian Ouyang
Dec 13, 2016·Hematological Oncology·Jung Yong HongSeok Jin Kim
Dec 31, 2016·Oncotarget·Jingxuan WangQingyuan Zhang
Apr 26, 2017·PloS One·Jin WangXiang Li
Citations
Feb 8, 2019·PloS One·Jie QinYuming Xu
Oct 20, 2019·Scientific Reports·Khee Ming TanJason Yongsheng Chan
Nov 20, 2019·Indian Journal of Otolaryngology and Head and Neck Surgery : Official Publication of the Association of Otolaryngologists of India·Mustafa ÇolakKürşat Murat Özcan
Aug 1, 2020·Journal of Clinical Medicine·Roberto TammaDomenico Ribatti
May 20, 2020·Cancer Management and Research·Paulina StefaniukMonika Podhorecka
Nov 29, 2020·Veterinary and Comparative Oncology·Joaquim HenriquesJane Dobson
Jan 31, 2021·Scientific Reports·Jongheon JungHyeon-Seok Eom
Nov 21, 2020·BMC Medicine·Meghan A CuppAntonio J Berlanga-Taylor
Feb 10, 2021·Leukemia Research·Denisse CastroJorge J Castillo